Clinical Trials
2 trialsNCT03612791 2026-04-03
ATEZOLACC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
NCT04884906 2021-05-13
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown